The effect of two drugs succinylcholine and cisatracurium in electroshock therapy.

Phase 3

• Conditions: Condition 1: Succinylcholine Chloride. Condition 2: cisatracurium.; Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], assault; T48.1X3

• Registration Number: IRCT20160307026950N14
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

People under the age of 18
American Society of Anesthesiology physical status class 1,2

Exclusion Criteria

Obesity (index is equal to or greater than 30
History of asthma
Allergy
Myocardial infarction in the last 6 months
Stroke in the last 6 weeks
Fibrillation and cardiac flutter
Repeated ectopic treatment at the same session
Having diseases like high blood pressure and hyperactivity

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum potassium levels. Timepoint: Before the administration of the anesthetic (baseline), before induction of the Electroshock (after administration of the drug), after the seizure, and 20 minutes after induction of anesthesia. Method of measurement: potassium test.